Avtor/Urednik		Rizvi, Ali A.; Popovic, Djordje S.; Papanas, Nikolaos; Pantea Stoian, Anca; Mahmeed, Wael Al; Sahebkar, Amirhossein; Janež, Andrej; Rizzo, Manfredi
Naslov		Current and emerging drugs for the treatment of atherosclerosis
Tip		članek
Leto izdaje		2022
Obseg		str. str.
ISSN		1477-9072 - Expert review of cardiovascular therapy
Jezik		eng
Abstrakt		Atherosclerosis can be considered a chronic inflammatory process that stands out as a dominant cause of cardiovascular disease (CVD). Since blood lipids are the leading risk factor for atherosclerosis development, lowering low-density lipoprotein cholesterol (LDL-C) and other apolipoprotein B-containing lipoproteins reduces the risk of future cardiovascular events. However, there has been significant progress in developing lipid-lowering drugs for aggressive management of dyslipidemia, the rates of CVD events remain unacceptably high, so there is great need to identify novel therapeutic pathways targeting the atherosclerosis process.
Proste vsebinske oznake		atherosclerosis lipoproteins developing drugs ateroskleroza lipoproteini razvoj zdravil